SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Northwest Biotherapeutics Inc.
NWBO 0.250+4.2%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: RikRichter12/21/2007 10:13:46 AM
   of 759
 
NWBO in the Financial Times today:

Rift Oil rises on gas reserves
By Robert Orr and Neil Hume

Published: December 21 2007 01:44 | Last updated: December 21 2007 01:44

Rift Oil was in the limelight on Thursday as dealers picked up on some eye-catching comments from Ian Gowrie-Smith, chairman.

Delivering the exploration group’s interim figures, the former boss of SkyePharma said Rift Oil had gas reserves in Papua New Guinea and a principle agreement with Rio Tinto-owned Alcan which had “the potential to be transformational”.

“We are looking at what could be worth billions,” he said. Rift Oil rose 8 per cent to 3?p, giving the company a market value of £23m ($45.7m, €31.9m).

Solar Integrated Technologies gained 12.1 per cent to 97p as the photovoltaic roofing group won a $70m contract in Italy, its largest to date, and announced a £14m fund raising.

McBride slumped 9.2 per cent to 110¾p as the white label goods manufacturer warned on the rising cost of raw materials.

Celtic rose 0.8 per cent to 64p as John Fisher, the US billionaire whose family founded the Gap clothing chain, took a 3.24 per cent interest in the Glasgow football club. Meanwhile, Premiership club Birmingham City was flat at 36½p in spite of news that talks with Carson Yeung, Hong Kong entrepreneur, had ended.

Northwest Biotherapeutics rose 3.1 per cent to 132½p after a push from Collins Stewart, which reiterated a “strong buy” and 300p price target. Analyst Navid Malik said the company had “the potential to redefine the personalised cancer vaccine space in 2008”.

William Ransom rebound­ed 18.2 per cent to 13p as its chief executive Timothy Dye, who is set to leave the pharmaceuticals group next month, bought 1.5m shares in the company.

DC Thomson, publisher of the Beano comic, appeared on the share register of SMG, owner of the Scottish television franchise, with a 3.87 per cent holding. SMG was unchanged at 16¼p.

The insurance run-off manager Randall & Quilter rose 12 per cent to 140p on its first day of trading after being brought to market by Numis Securities.

Copyright The Financial Times Limited 2007
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext